We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK
Splunk Inc
SPLK
+$446M
3
HES
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRON icon
326
Disc Medicine
IRON
$2.98B
$539K 0.02%
9,338
-13,783
-60% -$706K
VTR icon
327
Ventas
VTR
$47.6B
$518K 0.02%
+10,400
New +$466K
F icon
328
PUT
Ford
F
$56B
$518K 0.02%
740,900
– –
U icon
329
Unity
U
$18.6B
$511K 0.02%
+12,500
New +$385K
EDIT icon
330
Editas Medicine
EDIT
$442M
$507K 0.02%
50,000
-32,369
-39% -$284K
PHVS icon
331
Pharvaris
PHVS
$2.42B
$505K 0.02%
+18,000
New +$364K
PCVX icon
332
Vaxcyte
PCVX
$8.61B
$504K 0.02%
8,030
-1,970
-20% -$102K
VERU icon
333
Veru
VERU
$37.6M
$504K 0.02%
+70,000
New +$621K
VSTM icon
334
Verastem
VSTM
$561M
$503K 0.02%
61,803
-94,101
-60% -$676K
COTY icon
335
PUT
Coty
COTY
$2.47B
$498K 0.02%
1,418,000
– –
PRAX icon
336
Praxis Precision Medicines
PRAX
$9.75B
$496K 0.02%
22,278
-16,625
-43% -$299K
SAVE
337
DELISTED
Spirit Airlines, Inc.
SAVE
$492K 0.02%
30,000
-1,117,771
-97% -$16.1M
KVUE icon
338
Kenvue
KVUE
$36.9B
$481K 0.02%
22,336
-254,010
-92% -$5.08M
CRL icon
339
Charles River Laboratories
CRL
$12.5B
$481K 0.02%
2,034
-1,177
-37% -$231K
ESS icon
340
Essex Property Trust
ESS
$18.5B
$471K 0.01%
1,900
+100
+6% +$22.1K
IQV icon
341
IQVIA
IQV
$38.8B
$470K 0.01%
2,030
-2,605
-56% -$535K
OVID icon
342
Ovid Therapeutics
OVID
$489M
$465K 0.01%
144,500
-5,500
-4% -$18.8K
BNTX icon
343
BioNTech
BNTX
$23.3B
$460K 0.01%
4,363
+363
+9% +$36.6K
ACRV icon
344
Acrivon Therapeutics
ACRV
$73.2M
$460K 0.01%
93,443
-11,557
-11% -$61K
QTRX icon
345
Quanterix
QTRX
$187M
$459K 0.01%
16,794
-12,406
-42% -$292K
AVB icon
346
AvalonBay Communities
AVB
$26.8B
$456K 0.01%
+2,435
New +$425K
GDX icon
347
CALL
VanEck Gold Miners ETF
GDX
$27.2B
$452K 0.01%
400,000
-100,000
-20% -$2.93M
SLRN
348
DELISTED
ACELYRIN
SLRN
$448K 0.01%
+60,000
New +$512K
BCAB icon
349
BioAtla
BCAB
$5.59M
$444K 0.01%
3,608
-5,246
-59% -$455K
ZS icon
350
Zscaler
ZS
$27.1B
$443K 0.01%
2,000
-28,000
-93% -$5.19M
12 13
14
15 16

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.